We carry out projects related to the development of new diagnostic tools in cancer based on thermal liquid biopsy (TLB), the identification of bioactive compounds against various pathologies, and the use of polymeric nanostructures in therapy and diagnosis.
Main lines of research:
- TLB (Thermal Liquid Biopsy) applied to tumor pathology diagnosis: validation of a new rapid and non-invasive diagnostic method.
- Evaluation of polymeric nanostructures that can be used in drug delivery or specific detection of serum biomarkers.
- Identificación y caracterización de compuestos bioactivos frente a distintas dianas proteicas: NuPR1 (cáncer de páncreas), BFT3 (infección por Bacteroides fragilis), MeCP2 (Síndrome de Rett).
- Application of machine learning models to the analysis of clinical and biological data.